NEW YORK (GenomeWeb News) – Scientists at Harvard Medical School and its related institutions will use Exiqon's Locked Nucleic Acid microRNA Knockdown Library for high-throughput screening of small molecule and RNAi libraries, the Danish company said today.

Under the agreement, Harvard's ICCB-Longwood Screening Facility will serve as a microRNA Screening Center of Excellence, enabling it to provide the Exiqon technology to a new consortium of investigators at and affiliated with Harvard.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.

A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.

In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.

Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.